Bullous Pemphigoid Induced by antiPD-1/PDL-1 Therapy
NCT04641884
·
clinicaltrials.gov ↗
UNKNOWN
Status
85
Enrollment
OTHER
Sponsor class
Conditions
Bullous Pemphigoid
Immunotherapy
Programmed Cell Death Ligand 1
Interventions
OTHER:
Not concerned
Sponsor
Nantes University Hospital